Thermal Ablation

Seminars in Roentgenology

Volumn 46, Issue 2, 2011, Pages 133-141

  Webb, Heather ^a   Lubner, Meghan G ^a   Hinshaw, J Louis ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BONE METASTASIS; BREAST CANCER; BREAST FIBROADENOMA; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CRYOABLATION; DEVICE SAFETY; FLU LIKE SYNDROME; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; KIDNEY CARCINOMA; LASER SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METASTASIS; LUNG TUMOR; MICROWAVE THERAPY; NON INVASIVE PROCEDURE; OSTEOID OSTEOMA; PAIN; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY ABLATION; THERMAL ABLATION; TUMOR ABLATION; TUMOR LYSIS SYNDROME; TUMOR RECURRENCE; TUMOR SEEDING; TUMOR VOLUME; UTERUS MYOMA;

BONE NEOPLASMS; BREAST NEOPLASMS; CATHETER ABLATION; CRYOSURGERY; FEMALE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; KIDNEY NEOPLASMS; LASER THERAPY; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICROWAVES; NEOPLASMS; PROSTATIC NEOPLASMS;

EID: 79951693609     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2010.08.002     Document Type: Article

References (76)

1. Hinshaw J.L., Lee F.T. Image-guided ablation of renal tumors. New Techniques in Uroradiology 2006, Taylor and Francis, New York. S.K. Morcos, R.H. Cohen (Eds.).
2. Goldberg S.N., Gazelle G.S., Mueller P.R. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000, 174:323-331.
3. Brace C.L. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 2009, 38:135-143.
4. Wright A.S., Lee F.T., Mahvi D.M. Hepatic microwave ablation with multiple antennae results in synergistically larger zones of coagulation necrosis. Ann Surg Oncol 2003, 10:275-283.
5. Organ L.W. Electrophysiologic principles of radio frequency lesion making. Appl Neurophysiol 1976, 39:69-76.
6. Skinner M.G., Iizuka M.N., Kolios M.C., et al. A theoretical comparison of energy sources-microwave, ultrasound, and laser-for interstitial thermal therapy. Phys Med Biol 1998, 43:3535-3547.
7. Kennedy J.R., Ter Jaar G.R., Cranston D. High intensity focused ultrasound: surgery of the future?. Br J Radiol 2003, 76:590-599.
8. Kim Y., Rhim H., Choi M., et al. High intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol 2008, 9:291-302.
9. Kanaoka Y., Yoshida C., Fukuda T., et al. Transcervical microwave myolysis for uterine myomas assisted by transvaginal ultrasound guidance. J Obstet Gynaecol Res 2009, 35:717-724.
10. Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology 1977, 14:251-271.
11. Gill W., Fraser J., Carter D.C. Repeated freeze-thaw cycles in cryosurgery. Nature 1968, 219:410-413.
12. Boss A., Clasen S., Kuczyk M., et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol 2005, 40:583-590.
13. Hafez K.S., Fergany A.F., Novick A.C. Long term results of nephron-sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999, 162:1930-1933.
14. Butler B.P., Novick A.C., Miller D.P., et al. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology 1995, 45:34-40.
15. Gervais D., Mc Govern F., Arellano R., et al. Renal cell carcinoma: clinical experience and technical success with radiofrequency ablation of 42 tumors. Radiology 2003, 226:417-424.
16. McTaggart R.A., Dupuy D.E. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 2007, 10:102-113.
17. Goldberg S.N., Hahn P.F., Tanabe K.K., et al. Percutaneous radiofrequency ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 1998, 9:101-111.
18. Rhim H., Yoon K.H., Lee J.M., et al. Major complications after radio frequency thermal ablation of hepatic tumors: spectrum of imaging findings. RadioGraphics 2003, 23:123-134.
19. Rhim H., Goldberg S.N., Dodd G.D., et al. Essential techniques for successful radio frequency thermal ablation of malignant hepatic tumors. RadioGraphics 2001, 21:S17-S39.
20. Goldberg S.N., Gazelle G.S., Solbiati L., et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996, 3:636-644.
21. Lu D.S., Raman S.S., Vodopich D.J., et al. Effect of vessel size on creation of hepatic radio frequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002, 178:47-51.
22. Tungjitkusolmum S., Staelin S.T., Haemmerich D., et al. Three dimensional finite element analyses for radio frequency hepatic tumor ablation. IEEE Trans Biomed Eng 2002, 49:3-9.
23. Gannon C.J., Curley S.A. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol 2005, 15:265-272.
24. Weber S.M., Lee F.T., Warner T.F., et al. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology 1998, 207:73-77.
25. Winter T.C., Laeske P.F., Lee F.T. Focal tumor ablation: A new era in cancer therapy. Ultrasound Q 2006, 22:195-217.
26. Barugal M.E., Vargas C., Krygier Waltier G. Metastatic colorectal cancer: recent advances in its clinical management. Expert Rev Anticancer Ther 2009, 9:1829-1847.
27. Hinshaw J.L., Lee F.T. Cryoablation for Liver Cancer. Tech Vasc Interv Radiol 2007, 10:47-57.
28. Meloni M.F., Andreano A., Laeske P.F., et al. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation-intermediate and long-term survival rates. Radiology 2009, 253:861-869.
29. Jayson M., Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998, 51:203-205.
30. Roy-Chaudhury S., Cast J., Cooksey G., et al. Early experience with percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003, 180:1055-1061.
31. Farrell M.A., Charbonneau W.J., MeMarco D.S., et al. Image-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003, 180:1509-1513.
32. Rodriguez R., Chan D., Bishoff J., et al. Renal cryoablative surgery in selected patients with peripheral renal masses. Urology 2000, 55:25-30.
33. Zlotta A.R., Wildschutz T., Raviv G., et al. Radiofrequency interstitial tumor ablation is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997, 11:251-258.
34. Vogel T.J., Naguib N.N., Lehnert T., et al. Radiofrequency, microwave, and laser ablation of pulmonary neoplasms: clinical studies and technical considerations. Eur J Radiol 2009, 15:290-296.
35. Kim T.S., Lim H.K., Kim H. Excessive hyperthermic necrosis of a pulmonary lobe after hypertonic saline-enhanced monopolar radiofrequency ablation. Cardiovasc Interv Radiol 2006, 29:160-163.
36. Brace C.L., Hinshaw J.L., Laeske P.F., et al. Pulmonary thermal ablation: comparison of radio frequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 2009, 251:705-711.
37. Hinshaw JL, Littrup PJ, Durick N, et al: Optimizing the protocol for pulmonary cryoablation: a comparison of dual- and triple-freeze protocol. Cardiovasc Interv Radiol, in press.
38. Hinshaw J.L., Durick N.A., Leung W., et al. Radiology-pathology correlation of pulmonary cryoablation in a porcine model. Interv Onc J 2009, 2:113-120.
39. Callstrom M.R., Charboneau J.W., Goetz M.P., et al. Painful metastases involving bone: feasibility of percutaneous CT and US-guided radio-frequency ablation. Radiology 2003, 229:171-175.
40. Kojima H., Tanigawa N., Kariya S., et al. Clinical assessment of percutaneous radiofrequency ablation for painful metastatic bone tumors. Cardiovasc Interv Radiol 2006, 29:1022-1026.
41. Rosenthal D.I., Hornicek F.J., Torriani M., et al. Osteoid osteoma: percutaneous treatment with radio frequency energy. Radiology 2003, 229:171-175.
42. Ruiz S.F., Garcia M.M., Alvarez L.G., et al. Percutaneous treatment of bone tumors by radio frequency thermal ablation. Eur J Radiol 2009, (Epub ahead of print).
43. Fornage B.D., Sneige N., Ross M.I., et al. Small (less than or equal to 2 cm) breast cancer treated with US guided radiofrequency ablation: feasibility study. Radiology 2004, 231:215-224.
44. Bland K.L., Gass J., Klimberg V. Radiofrequency, cryoablation, and other modalities for breast cancer ablation. Surg Clin North Am 2007, 87:539-550.
45. Huston T.L., Simmons R.M. Ablative therapies for the treatment of malignant disease of the breast. Am J Surg 2005, 189:694-701.
46. Kaufman C.S., Littrup P.J., Freeman-Gibb L.A., et al. Office-based cryoablation of breast fibroadenomas with long-term follow-up. Breast J 2005, 11:344-350.
47. Nurko J., Mabry C.D., Whitworth P., et al. Interim results from the FibroAdenoma cryoablation Treatment Registry. Am J Surg 2005, 190:647-651.
48. Maestroni U., Ziveri M., Azzolini N., et al. High intensity focused ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results. Acta Biol Med 2008, 79:211-216.
49. Blana A., Walter B., Rogenhofer S., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 2004, 63:297-300.
50. Thüroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the european multicentric study. J of Endourol 2003, 17:673-677.
51. Bahn D.K., Silverman P., Lee F., et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006, 20:688-692.
52. Jones J.S., Rewcastle J.C., Donnelly B.J., et al. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008, 180:554-558.
53. Kim Y.S., Rhim H., Choi M.J., et al. high intensity focused ultrasound therapy: an overview for radiologists. Korean J Radiol 2008, 9:291-302.
54. Pacella C.M., Bizzarri G., Spiezia S., et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 2004, 232:272-280.
55. Goldberg S.N., Charboneau J.W., Dodd G.D., et al. Image guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003, 228:335-345.
56. Sheafor D.H., Paulson E.K., Simmons C.M., et al. Abdominal percutaneous interventional procedures: comparison of CT and US guidance. Radiology 1998, 207:705-710.
57. Kliewer M.A., Sheafor D.H., Paulson E.K., et al. Percutaneous liver biopsy: a cost-benefit analysis comparing sonographic and CT guidance. AJR Am J Roentgenol 1999, 173:1199-1202.
58. Wen Y.L., Kudo M., Zheng R.Q., et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003, 181:57-63.
59. Magami T., Harada J., Kishimoto K., et al. Percutaneous MR-guided cryoablation for malignancies, with a focus on renal cell carcinoma. Int J Clin Oncol 2007, 12:79-84.
60. Brace C.L., Sampson L.A., Hinshaw J.L., et al. Radiofrequency ablation: simultaneous application of multiple electrodes via switching creates larger, more confluent ablations than sequential application in a large animal model. J Vasc Interv Radiol 2009, 20:118-124.
61. Hinshaw J.L., Shadid A.M., Nakada S.Y., et al. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol 2008, 191:1159-1168.
62. Hui G.C., Tuncali K., Tatli S., et al. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates. J Vasc Interv Radiol 2008, 19:1311-1320.
63. Rhim H., Lim H.K., Kim Y.S., et al. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol 2008, 190:91-98.
64. Hinshaw J.L., Laeske P., Winter T.C., et al. Radiofrequency ablation of peripheral liver tumors: intra-peritoneal. 5 % dextrose in water (D5W) decreases post-procedure pain. AJR Am J Roentgenol 2006, 186:S306-S310.
65. Froemming A., Atwell T., Farrell M., et al. Probe retraction during renal cryablation: a technique to minimize direct ureteral injury. J Vasc Interv Radiol 2010, 21:148-151.
66. Cantwell C.P., Wah T.M., Gervais D.A., et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol 2008, 19:1034-1040.
67. Harb T, Littrup PJ, Silva j, et al: Cryotherapy of primary renal cell carcinoma and local recurrences after nephrectomy: techniques and early outcomes: RSNA Scientific Assembly And Annual Meeting Program, p 495, 2003.
68. Wah T.M., Arellano R.S., Gervais D.A., et al. Image-guided percutaneous radiofrequency ablation and incidence of post-radiofrequency ablation syndrome: prospective survey. Radiology 2005, 237. 1097-1002.
69. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226:441-451.
70. de Baere T., Risse O., Kuoch V., et al. Adverse events during radio frequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003, 181:695-700.
71. Poon R.T., Ng K.K., Lam C.M., et al. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004, 11:281-289.
72. Llovet J.M., Vilana R., Bianchi L., et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. J Hepatol 2001, 33:1124-1129.
73. Seifert J.K., Morris D.L. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999, 23:109-113.
74. Lehner S.G., Gould J.E., Saad W.E., et al. Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma. AJR Am J Roentgenol 2005, 185:1307-1309.
75. Bagia J.S., Perera D.S., Morris D.L. Renal impairment in hepatic cryotherapy. Cryobiology 1998, 36:263-267.
76. Seifert J.K., Stewart G.J., Hewitt P.M., et al. Interleukin-6 and tumor necrosis factor -alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999, 23:1019-1026.